The DOI matches its Crossref record; 15 of the 21 references it cites were found in a registry or an index.
Treatment of Severe Postmenopausal Endometriosis With an Aromatase Inhibitor
Open accessAbstract
Objective To treat an unusually aggressive case of recurrent postmenopausal endometriosis. Design Case report. Setting University of Texas Southwestern Medical Center (Dallas, Texas). Patient(s) A 57-year-old woman who presented with recurrent severe endometriosis after hysterectomy and bilateral salpingo-oophorectomy. Intervention(s) Oral administration of anastrozole (an aromatase inhibitor) (1 mg/d) and elemental calcium (1.5 g/d) for 9 months. Alendronate (a nonestrogenic inhibitor of bone resorption), 10 mg/d, was added to this regimen. Main outcome measure(s) Reduction in size of endometriotic lesion, pain relief, tissue levels of aromatase P450 messenger RNA, bone density. Result(s) Circulating levels of estradiol-17beta were reduced to approximately 50% of the baseline value after the onset of treatment with anastrozole. Pain rapidly decreased and completely disappeared after the 2nd month of treatment. The 30 x 30 x 20-mm bright red polypoid vaginal lesion was reduced to a 3-mm gray tissue by the end of 9 months of treatment. Markedly high pretreatment levels of aromatase P450 messenger RNA in the endometriotic tissue became undetectable in a specimen obtained from a repeated biopsy after 6 months of treatment. Bone density of lumbar spine decreased by 6.2% after 9 months of treatment. Conclusion(s) This is the first description of the use of an aromatase inhibitor in the treatment of endometriosis. The short-term results were extraordinarily successful in eliminatio…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Endometriosis is an estrogen-dependent inflammatory disease that occurs in women of reproductive age, and generally becomes inactive with menopause, unless a woman uses post-menopausal hormone therapy (Goodman et al., 1989;Takayama et al., 1998;Missmer et al., 2004;Cumiskey et al., 2008).”
From Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications (2011) · cites this paper as Takayama et al., 1998
Citations
Cites
Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07088-2 · Cited by 3,846
Aromatase Cytochrome P450, The Enzyme Responsible for Estrogen Biosynthesis*
SIMPSON, E. R., MAHENDROO, M. S., MEANS, G. D., KILGORE, M. W., HINSHELWOOD, M. M., GRAHAM-LORENCE, S., AMARNEH, B., ITO, Y., FISHER, C. R., MICHAEL, M. D., et al. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-3-342 · Cited by 1,537
Self-citationAromatase expression in endometriosis.
Noble, L. S., Simpson, E. R., Johns, A., & Bulun, S. E. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550748 · Cited by 566
Self-citationAdministration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis
Henzl, M. R., Corson, S. L., Moghissi, K., Buttram, V. C., Berqvist, C., & Jacobson, J. (1988) · New England Journal of Medicine · doi:10.1056/nejm198802253180805 · Cited by 361
Bulun, S. E., Price, T. M., Aitken, J., Mahendroo, M. S., & Simpson, E. R. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.6.8117355 · Cited by 335
Self-citationProstaglandin E2 Stimulates Aromatase Expression in Endometriosis-Derived Stromal Cells
Noble, L. S. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.600 · Cited by 301
Self-citationAgarwal, V. R. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.11.3843 · Cited by 258
Self-citationGonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up
Waller, K. G., & Shaw, R. W. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)55791-4 · Cited by 252
Devogelaer, J. P., Broll, H., Correa-Rotter, R., Cumming, D. C., Nagant de Deuxchaisnes, C., Geusens, P., Hosking, D., Jaeger, P., Kaufman, J. M., Leite, M., et al. (1996) · Bone · doi:10.1016/8756-3282(95)00436-x · Cited by 191
Bulun, S. E. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.2.428 · Cited by 188
Self-citation
Research works printed but not linked: 3
- Bulun, 1994, Competitive RT-PCR analysis indicates levels of aromatase cytochrome P450 transcripts in adipose tissue of buttocks, thighs, and abdomen of women increase with advancing age, J Clin Endocrinol Metab, 78, 428
- Huang, 1996, Regulation of cyclooxygenase-2 gene in cultured endometrial stromal cells by sex steroids [abstract], Am Soc Reprod Med, 5S
- Zeitoun, 1997, Conversion of estrone to estradiol is increased in endometriosis compared with the endometrium [abstract], J Soc Gynecol Invest, 4, 239A
Cited by
Giudice, L. C., & Kao, L. C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17403-5 · Cited by 3,166
Bulun, S. E. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804690 · Cited by 1,772
Self-citationEndometriosis is a chronic systemic disease: Clinical challenges and novel innovations
Taylor, H. S., Kotlyar, A. M., & Flores, V. A. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00389-5 · Cited by 1,425
Bulun, S. E., Yilmaz, B. D., Sison, C., Miyazaki, K., Bernardi, L., Liu, S., Kohlmeier, A., Yin, P., Milad, M., & Wei, J. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00242 · Cited by 844
Self-citationBulun, S. E., Lin, Z., Imir, G., Amin, S., Demura, M., Yilmaz, B., Martin, R., Utsunomiya, H., Thung, S., Gurates, B., et al. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.3.6 · Cited by 531
“We introduced aromatase inhibitors into the treatment of endometriosis in 1998 by a case report of postmenopausal endometriosis (Takayama et al., 1998) (Fig.”
InfluentialSelf-citation
Metadata
- Authors
- Takayama, K., Zeitoun, K., Gunby, R. T., Sasano, H., Carr, B. R., & Bulun, S. E.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Baylor University (US)
- Tohoku University (JP)
- Corresponding author
- Bulun, Serdar E
- Venue
- Fertility and Sterility
- Publisher
- Elsevier BV
- Published
- 1998-04
- Volume
- 69
- Issue
- 4
- Pages
- 709-713
- ISSN
- 0015-0282 (ISSN-L)
- OpenAlex
- W2092919766
- Cited by
- 270
- References
- 21
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 4 · 2023: 5 · 2022: 5 · 2021: 9 · 2020: 10 · 2019: 8 · 2018: 2 · 2017: 1 · 2016: 7 · 2015: 15 · 2014: 9 · 2013: 6 · 2012: 9
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 8822 d)
- Locations
- Fertility and Sterility (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
- Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
- Keywords
- postmenopausal endometriosis, aromatase inhibitors, anastrozole, recurrent endometriosis, analgesia, alendronate, bone mineral loss, salpingo-oophorectomy, hysterectomy
- MeSH terms
- Anastrozole, Administration, Oral, Animals, Aromatase, Biopsy, Endometriosis, Enzyme Inhibitors, Female, Humans, Middle Aged, Nitriles, Recurrence, RNA, Messenger, Time Factors, Triazoles, Polymerase Chain Reaction, Postmenopause, Aromatase Inhibitors, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of Severe Postmenopausal Endometriosis With an Aromatase Inhibitor. https://app.cochat.ai/papers/10.1016/s0015-0282(98)00022-3
- The paper
- Takayama, K., Zeitoun, K., Gunby, R. T., Sasano, H., Carr, B. R., & Bulun, S. E. (1998). Treatment of Severe Postmenopausal Endometriosis With an Aromatase Inhibitor. Fertility and Sterility. https://doi.org/10.1016/s0015-0282(98)00022-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.